+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biosimulation Market Research Report by Product & Service, by Delivery Model, by End-user, by Application, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5454874
  • Report
  • January 2022
  • Region: Global
  • 214 Pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2022

FEATURED COMPANIES

  • Certara
  • Evidera
  • In silico biosciences
  • Insilico Biotechnology AG
  • Nuventra Pharma Sciences
  • Rosa & Co. LLC.
The Global Biosimulation Market size was estimated at USD 2,112.80 million in 2020, is expected to reach USD 2,461.84 million in 2021, and is projected to grow at a CAGR of 16.88% to reach USD 6,297.89 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biosimulation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market was studied across Services and Software. The Services is further studied across Contract Services and In-house Services. The Software is further studied across Molecular Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Pk/Pd Modeling and Simulation Software, Toxicity Prediction Software, and Trial Design Software.
  • Based on Delivery Model, the market was studied across Ownership Models and Subscription Models.
  • Based on End-user, the market was studied across Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Regulatory Authorities, and Research Institutes.
  • Based on Application, the market was studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing. The Preclinical Testing is further studied across Adme/Tox and Pk/Pd. The Drug Discovery is further studied across Lead Identification and Optimization and Target Identification and Validation.
  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biosimulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biosimulation Market, including Advanced Chemistry Development, Certara, Chemical Computing Group ULC, Dassault Systèmes, Evidera, Gendata AG, In silico biosciences, INOSIM Software, Insilico Biotechnology AG, LeadInvent Pharma Inc, Nuventra Pharma Sciences, Physiomics Plc, Rosa & Co. LLC., Schrödinger, Inc., and Simulations Plus.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biosimulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biosimulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biosimulation Market?
4. What is the competitive strategic window for opportunities in the Global Biosimulation Market?
5. What are the technology trends and regulatory frameworks in the Global Biosimulation Market?
6. What is the market share of the leading vendors in the Global Biosimulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Biosimulation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Certara
  • Evidera
  • In silico biosciences
  • Insilico Biotechnology AG
  • Nuventra Pharma Sciences
  • Rosa & Co. LLC.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to adaptations of biosimulation in various sectors such as biotechnology
5.1.1.2. Growing demand associated with application of biosimulation in clinical trials
5.1.1.3. Rising investments in drug developments and drug testings
5.1.2. Restraints
5.1.2.1. Upscaled prices involved in installations and technique developments for biosimulation
5.1.3. Opportunities
5.1.3.1. Favorable governmental laws and regulations to implement biosimulation
5.1.3.2. Increasing investments in research and development for utilization of biosimulation
5.1.4. Challenges
5.1.4.1. Lack of awareness coupled with scarcity of professionals for research and development
5.2. Cumulative Impact of COVID-19

6. Biosimulation Market, by Product & Service
6.1. Introduction
6.2. Services
6.2.1. Contract Services
6.2.2. In-house Services
6.3. Software
6.3.1. Molecular Modeling and Simulation Software
6.3.2. Pbpk Modeling and Simulation Software
6.3.3. Pk/Pd Modeling and Simulation Software
6.3.4. Toxicity Prediction Software
6.3.5. Trial Design Software

7. Biosimulation Market, by Delivery Model
7.1. Introduction
7.2. Ownership Models
7.3. Subscription Models

8. Biosimulation Market, by End-user
8.1. Introduction
8.2. Contract Research Organizations
8.3. Pharmaceutical And Biotechnology Companies
8.4. Regulatory Authorities
8.5. Research Institutes

9. Biosimulation Market, by Application
9.1. Introduction
9.2. Drug Development
9.2.1. Clinical Trials
9.2.2. Preclinical Testing
9.2.2.1. Adme/Tox
9.2.2.2. Pk/Pd
9.3. Drug Discovery
9.3.1. Lead Identification and Optimization
9.3.2. Target Identification and Validation

10. Americas Biosimulation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biosimulation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Biosimulation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Advanced Chemistry Development
14.2. Certara
14.3. Chemical Computing Group ULC
14.4. Dassault Systèmes
14.5. Evidera
14.6. Gendata AG
14.7. In silico biosciences
14.8. INOSIM Software
14.9. Insilico Biotechnology AG
14.10. LeadInvent Pharma Inc
14.11. Nuventra Pharma Sciences
14.12. Physiomics Plc
14.13. Rosa & Co. LLC.
14.14. Schrödinger, Inc.
14.15. Simulations Plus

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing


List of Figures
Figure 1. Global Biosimulation Market: Research Process
Figure 2. Global Biosimulation Market: Market Dynamics
Figure 3. Global Biosimulation Market Size, by Product & Service, 2020 Vs 2027 (%)
Figure 4. Global Biosimulation Market Size, by Product & Service, 2020 Vs 2027 (USD Million)
Figure 5. Competitive Strategic Window For Global Biosimulation Market Size, by Product & Service, 2027
Figure 6. Global Biosimulation Market Size, by Services, 2018-2027 (USD Million)
Figure 7. Global Biosimulation Market Size, by Services, by Region, 2020 Vs 2027 (USD Million)
Figure 8. Global Biosimulation Market Size, by Contract Services, 2018-2027 (USD Million)
Figure 9. Global Biosimulation Market Size, by Contract Services, by Region, 2020 Vs 2027 (USD Million)
Figure 10. Global Biosimulation Market Size, by In-House Services, 2018-2027 (USD Million)
Figure 11. Global Biosimulation Market Size, by In-House Services, by Region, 2020 Vs 2027 (USD Million)
Figure 12. Global Biosimulation Market Size, by Software, 2018-2027 (USD Million)
Figure 13. Global Biosimulation Market Size, by Software, by Region, 2020 Vs 2027 (USD Million)
Figure 14. Global Biosimulation Market Size, by Molecular Modeling And Simulation Software, 2018-2027 (USD Million)
Figure 15. Global Biosimulation Market Size, by Molecular Modeling And Simulation Software, by Region, 2020 Vs 2027 (USD Million)
Figure 16. Global Biosimulation Market Size, by Pbpk Modeling And Simulation Software, 2018-2027 (USD Million)
Figure 17. Global Biosimulation Market Size, by Pbpk Modeling And Simulation Software, by Region, 2020 Vs 2027 (USD Million)
Figure 18. Global Biosimulation Market Size, by Pk/Pd Modeling And Simulation Software, 2018-2027 (USD Million)
Figure 19. Global Biosimulation Market Size, by Pk/Pd Modeling And Simulation Software, by Region, 2020 Vs 2027 (USD Million)
Figure 20. Global Biosimulation Market Size, by Toxicity Prediction Software, 2018-2027 (USD Million)
Figure 21. Global Biosimulation Market Size, by Toxicity Prediction Software, by Region, 2020 Vs 2027 (USD Million)
Figure 22. Global Biosimulation Market Size, by Trial Design Software, 2018-2027 (USD Million)
Figure 23. Global Biosimulation Market Size, by Trial Design Software, by Region, 2020 Vs 2027 (USD Million)
Figure 24. Global Biosimulation Market Size, by Delivery Model, 2020 Vs 2027 (%)
Figure 25. Global Biosimulation Market Size, by Delivery Model, 2020 Vs 2027 (USD Million)
Figure 26. Competitive Strategic Window For Global Biosimulation Market Size, by Delivery Model, 2027
Figure 27. Global Biosimulation Market Size, by Ownership Models, 2018-2027 (USD Million)
Figure 28. Global Biosimulation Market Size, by Ownership Models, by Region, 2020 Vs 2027 (USD Million)
Figure 29. Global Biosimulation Market Size, by Subscription Models, 2018-2027 (USD Million)
Figure 30. Global Biosimulation Market Size, by Subscription Models, by Region, 2020 Vs 2027 (USD Million)
Figure 31. Global Biosimulation Market Size, by End-User, 2020 Vs 2027 (%)
Figure 32. Global Biosimulation Market Size, by End-User, 2020 Vs 2027 (USD Million)
Figure 33. Competitive Strategic Window For Global Biosimulation Market Size, by End-User, 2027
Figure 34. Global Biosimulation Market Size, by Contract Research Organizations, 2018-2027 (USD Million)
Figure 35. Global Biosimulation Market Size, by Contract Research Organizations, by Region, 2020 Vs 2027 (USD Million)
Figure 36. Global Biosimulation Market Size, by Pharmaceutical And Biotechnology Companies, 2018-2027 (USD Million)
Figure 37. Global Biosimulation Market Size, by Pharmaceutical And Biotechnology Companies, by Region, 2020 Vs 2027 (USD Million)
Figure 38. Global Biosimulation Market Size, by Regulatory Authorities, 2018-2027 (USD Million)
Figure 39. Global Biosimulation Market Size, by Regulatory Authorities, by Region, 2020 Vs 2027 (USD Million)
Figure 40. Global Biosimulation Market Size, by Research Institutes, 2018-2027 (USD Million)
Figure 41. Global Biosimulation Market Size, by Research Institutes, by Region, 2020 Vs 2027 (USD Million)
Figure 42. Global Biosimulation Market Size, by Application, 2020 Vs 2027 (%)
Figure 43. Global Biosimulation Market Size, by Application, 2020 Vs 2027 (USD Million)
Figure 44. Competitive Strategic Window For Global Biosimulation Market Size, by Application, 2027
Figure 45. Global Biosimulation Market Size, by Drug Development, 2018-2027 (USD Million)
Figure 46. Global Biosimulation Market Size, by Drug Development, by Region, 2020 Vs 2027 (USD Million)
Figure 47. Global Biosimulation Market Size, by Clinical Trials, 2018-2027 (USD Million)
Figure 48. Global Biosimulation Market Size, by Clinical Trials, by Region, 2020 Vs 2027 (USD Million)
Figure 49. Global Biosimulation Market Size, by Preclinical Testing, 2018-2027 (USD Million)
Figure 50. Global Biosimulation Market Size, by Preclinical Testing, by Region, 2020 Vs 2027 (USD Million)
Figure 51. Global Biosimulation Market Size, by Adme/Tox, 2018-2027 (USD Million)
Figure 52. Global Biosimulation Market Size, by Adme/Tox, by Region, 2020 Vs 2027 (USD Million)
Figure 53. Global Biosimulation Market Size, by Pk/Pd, 2018-2027 (USD Million)
Figure 54. Global Biosimulation Market Size, by Pk/Pd, by Region, 2020 Vs 2027 (USD Million)
Figure 55. Global Biosimulation Market Size, by Drug Discovery, 2018-2027 (USD Million)
Figure 56. Global Biosimulation Market Size, by Drug Discovery, by Region, 2020 Vs 2027 (USD Million)
Figure 57. Global Biosimulation Market Size, by Lead Identification And Optimization, 2018-2027 (USD Million)
Figure 58. Global Biosimulation Market Size, by Lead Identification And Optimization, by Region, 2020 Vs 2027 (USD Million)
Figure 59. Global Biosimulation Market Size, by Target Identification And Validation, 2018-2027 (USD Million)
Figure 60. Global Biosimulation Market Size, by Target Identification And Validation, by Region, 2020 Vs 2027 (USD Million)
Figure 61. Americas Biosimulation Market Size, 2018-2027 (USD Million)
Figure 62. Argentina Biosimulation Market Size, 2018-2027 (USD Million)
Figure 63. Brazil Biosimulation Market Size, 2018-2027 (USD Million)
Figure 64. Canada Biosimulation Market Size, 2018-2027 (USD Million)
Figure 65. Mexico Biosimulation Market Size, 2018-2027 (USD Million)
Figure 66. United States Biosimulation Market Size, 2018-2027 (USD Million)
Figure 67. Asia-Pacific Biosimulation Market Size, 2018-2027 (USD Million)
Figure 68. Australia Biosimulation Market Size, 2018-2027 (USD Million)
Figure 69. China Biosimulation Market Size, 2018-2027 (USD Million)
Figure 70. India Biosimulation Market Size, 2018-2027 (USD Million)
Figure 71. Indonesia Biosimulation Market Size, 2018-2027 (USD Million)
Figure 72. Japan Biosimulation Market Size, 2018-2027 (USD Million)
Figure 73. Malaysia Biosimulation Market Size, 2018-2027 (USD Million)
Figure 74. Philippines Biosimulation Market Size, 2018-2027 (USD Million)
Figure 75. Singapore Biosimulation Market Size, 2018-2027 (USD Million)
Figure 76. South Korea Biosimulation Market Size, 2018-2027 (USD Million)
Figure 77. Taiwan Biosimulation Market Size, 2018-2027 (USD Million)
Figure 78. Thailand Biosimulation Market Size, 2018-2027 (USD Million)
Figure 79. Europe, Middle East & Africa Biosimulation Market Size, 2018-2027 (USD Million)
Figure 80. France Biosimulation Market Size, 2018-2027 (USD Million)
Figure 81. Germany Biosimulation Market Size, 2018-2027 (USD Million)
Figure 82. Italy Biosimulation Market Size, 2018-2027 (USD Million)
Figure 83. Netherlands Biosimulation Market Size, 2018-2027 (USD Million)
Figure 84. Qatar Biosimulation Market Size, 2018-2027 (USD Million)
Figure 85. Russia Biosimulation Market Size, 2018-2027 (USD Million)
Figure 86. Saudi Arabia Biosimulation Market Size, 2018-2027 (USD Million)
Figure 87. South Africa Biosimulation Market Size, 2018-2027 (USD Million)
Figure 88. Spain Biosimulation Market Size, 2018-2027 (USD Million)
Figure 89. United Arab Emirates Biosimulation Market Size, 2018-2027 (USD Million)
Figure 90. United Kingdom Biosimulation Market Size, 2018-2027 (USD Million)
Figure 91. Global Biosimulation Market: Fpnv Positioning Matrix
Figure 92. Global Biosimulation Market: Share, by Key Player, 2020
Figure 93. Competitive Scenario Analysis In Global Biosimulation Market, by Type


List of Tables
Table 1. Global Biosimulation Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. Global Biosimulation Market Size, by Product & Service, 2018-2027 (USD Million)
Table 4. Global Biosimulation Market Size, by Services, by Region, 2018-2027 (USD Million)
Table 5. Global Biosimulation Market Size, by Contract Services, by Region, 2018-2027 (USD Million)
Table 6. Global Biosimulation Market Size, by In-House Services, by Region, 2018-2027 (USD Million)
Table 7. Global Biosimulation Market Size, by Software, by Region, 2018-2027 (USD Million)
Table 8. Global Biosimulation Market Size, by Molecular Modeling And Simulation Software, by Region, 2018-2027 (USD Million)
Table 9. Global Biosimulation Market Size, by Pbpk Modeling And Simulation Software, by Region, 2018-2027 (USD Million)
Table 10. Global Biosimulation Market Size, by Pk/Pd Modeling And Simulation Software, by Region, 2018-2027 (USD Million)
Table 11. Global Biosimulation Market Size, by Toxicity Prediction Software, by Region, 2018-2027 (USD Million)
Table 12. Global Biosimulation Market Size, by Trial Design Software, by Region, 2018-2027 (USD Million)
Table 13. Global Biosimulation Market Size, by Delivery Model, 2018-2027 (USD Million)
Table 14. Global Biosimulation Market Size, by Ownership Models, by Region, 2018-2027 (USD Million)
Table 15. Global Biosimulation Market Size, by Subscription Models, by Region, 2018-2027 (USD Million)
Table 16. Global Biosimulation Market Size, by End-User, 2018-2027 (USD Million)
Table 17. Global Biosimulation Market Size, by Contract Research Organizations, by Region, 2018-2027 (USD Million)
Table 18. Global Biosimulation Market Size, by Pharmaceutical And Biotechnology Companies, by Region, 2018-2027 (USD Million)
Table 19. Global Biosimulation Market Size, by Regulatory Authorities, by Region, 2018-2027 (USD Million)
Table 20. Global Biosimulation Market Size, by Research Institutes, by Region, 2018-2027 (USD Million)
Table 21. Global Biosimulation Market Size, by Application, 2018-2027 (USD Million)
Table 22. Global Biosimulation Market Size, by Drug Development, by Region, 2018-2027 (USD Million)
Table 23. Global Biosimulation Market Size, by Clinical Trials, by Region, 2018-2027 (USD Million)
Table 24. Global Biosimulation Market Size, by Preclinical Testing, by Region, 2018-2027 (USD Million)
Table 25. Global Biosimulation Market Size, by Adme/Tox, by Region, 2018-2027 (USD Million)
Table 26. Global Biosimulation Market Size, by Pk/Pd, by Region, 2018-2027 (USD Million)
Table 27. Global Biosimulation Market Size, by Drug Discovery, by Region, 2018-2027 (USD Million)
Table 28. Global Biosimulation Market Size, by Lead Identification And Optimization, by Region, 2018-2027 (USD Million)
Table 29. Global Biosimulation Market Size, by Target Identification And Validation, by Region, 2018-2027 (USD Million)
Table 30. Americas Biosimulation Market Size, 2018-2027 (USD Million)
Table 31. Argentina Biosimulation Market Size, 2018-2027 (USD Million)
Table 32. Brazil Biosimulation Market Size, 2018-2027 (USD Million)
Table 33. Canada Biosimulation Market Size, 2018-2027 (USD Million)
Table 34. Mexico Biosimulation Market Size, 2018-2027 (USD Million)
Table 35. United States Biosimulation Market Size, 2018-2027 (USD Million)
Table 36. Asia-Pacific Biosimulation Market Size, 2018-2027 (USD Million)
Table 37. Australia Biosimulation Market Size, 2018-2027 (USD Million)
Table 38. China Biosimulation Market Size, 2018-2027 (USD Million)
Table 39. India Biosimulation Market Size, 2018-2027 (USD Million)
Table 40. Indonesia Biosimulation Market Size, 2018-2027 (USD Million)
Table 41. Japan Biosimulation Market Size, 2018-2027 (USD Million)
Table 42. Malaysia Biosimulation Market Size, 2018-2027 (USD Million)
Table 43. Philippines Biosimulation Market Size, 2018-2027 (USD Million)
Table 44. Singapore Biosimulation Market Size, 2018-2027 (USD Million)
Table 45. South Korea Biosimulation Market Size, 2018-2027 (USD Million)
Table 46. Taiwan Biosimulation Market Size, 2018-2027 (USD Million)
Table 47. Thailand Biosimulation Market Size, 2018-2027 (USD Million)
Table 48. Europe, Middle East & Africa Biosimulation Market Size, 2018-2027 (USD Million)
Table 49. France Biosimulation Market Size, 2018-2027 (USD Million)
Table 50. Germany Biosimulation Market Size, 2018-2027 (USD Million)
Table 51. Italy Biosimulation Market Size, 2018-2027 (USD Million)
Table 52. Netherlands Biosimulation Market Size, 2018-2027 (USD Million)
Table 53. Qatar Biosimulation Market Size, 2018-2027 (USD Million)
Table 54. Russia Biosimulation Market Size, 2018-2027 (USD Million)
Table 55. Saudi Arabia Biosimulation Market Size, 2018-2027 (USD Million)
Table 56. South Africa Biosimulation Market Size, 2018-2027 (USD Million)
Table 57. Spain Biosimulation Market Size, 2018-2027 (USD Million)
Table 58. United Arab Emirates Biosimulation Market Size, 2018-2027 (USD Million)
Table 59. United Kingdom Biosimulation Market Size, 2018-2027 (USD Million)
Table 60. Global Biosimulation Market: Scores
Table 61. Global Biosimulation Market: Business Strategy
Table 62. Global Biosimulation Market: Product Satisfaction
Table 63. Global Biosimulation Market: Ranking
Table 64. Global Biosimulation Market: Share, by Key Player, 2020
Table 65. Global Biosimulation Market: Merger & Acquisition
Table 66. Global Biosimulation Market: Agreement, Collaboration, & Partnership
Table 67. Global Biosimulation Market: New Product Launch & Enhancement
Table 68. Global Biosimulation Market: Investment & Funding
Table 69. Global Biosimulation Market: Award, Recognition, & Expansion
Table 70. Global Biosimulation Market: License & Pricing
Note: Product cover images may vary from those shown
  • Advanced Chemistry Development
  • Certara
  • Chemical Computing Group ULC
  • Dassault Systèmes
  • Evidera
  • Gendata AG
  • In silico biosciences
  • INOSIM Software
  • Insilico Biotechnology AG
  • LeadInvent Pharma Inc
  • Nuventra Pharma Sciences
  • Physiomics Plc
  • Rosa & Co. LLC.
  • Schrödinger, Inc.
  • Simulations Plus
Note: Product cover images may vary from those shown

Loading
LOADING...